Abstract

Physical activity and molecular ageing presumably interact to precipitate musculoskeletal decline in humans with age. Herein, we have delineated molecular networks for these two major components of sarcopenic risk using multiple independent clinical cohorts. We generated genome-wide transcript profiles from individuals (n = 44) who then undertook 20 weeks of supervised resistance-exercise training (RET). Expectedly, our subjects exhibited a marked range of hypertrophic responses (3% to +28%), and when applying Ingenuity Pathway Analysis (IPA) up-stream analysis to ∼580 genes that co-varied with gain in lean mass, we identified rapamycin (mTOR) signaling associating with growth (P = 1.4×10−30). Paradoxically, those displaying most hypertrophy exhibited an inhibited mTOR activation signature, including the striking down-regulation of 70 rRNAs. Differential analysis found networks mimicking developmental processes (activated all-trans-retinoic acid (ATRA, Z-score = 4.5; P = 6×10−13) and inhibited aryl-hydrocarbon receptor signaling (AhR, Z-score = −2.3; P = 3×10−7)) with RET. Intriguingly, as ATRA and AhR gene-sets were also a feature of endurance exercise training (EET), they appear to represent “generic” physical activity responsive gene-networks. For age, we found that differential gene-expression methods do not produce consistent molecular differences between young versus old individuals. Instead, utilizing two independent cohorts (n = 45 and n = 52), with a continuum of subject ages (18–78 y), the first reproducible set of age-related transcripts in human muscle was identified. This analysis identified ∼500 genes highly enriched in post-transcriptional processes (P = 1×10−6) and with negligible links to the aforementioned generic exercise regulated gene-sets and some overlap with ribosomal genes. The RNA signatures from multiple compounds all targeting serotonin, DNA topoisomerase antagonism, and RXR activation were significantly related to the muscle age-related genes. Finally, a number of specific chromosomal loci, including 1q12 and 13q21, contributed by more than chance to the age-related gene list (P = 0.01–0.005), implying possible epigenetic events. We conclude that human muscle age-related molecular processes appear distinct from the processes regulated by those of physical activity.

Highlights

  • IntroductionDiscovery of the biological determinants of muscle mass and functional molecular phenotypes has substantial bearing on the fields of human performance (e.g. hypertrophy, strength or endurance adaptations [1,2]) and human health (countering muscle atrophy and deconditioning occurring in older age or with conditions such as cancer cachexia [3,4], respiratory disease or medically enforced immobilization (e.g. hospitalized bed-rest, cast-immobilization [5,6]))

  • Discovery of the biological determinants of muscle mass and functional molecular phenotypes has substantial bearing on the fields of human performance and human health (countering muscle atrophy and deconditioning occurring in older age or with conditions such as cancer cachexia [3,4], respiratory disease or medically enforced immobilization)

  • We combined this analysis with extensive data on the impact of exercise training on human muscle phenotype to identify the processes predominately associated with age and not environment

Read more

Summary

Introduction

Discovery of the biological determinants of muscle mass and functional molecular phenotypes has substantial bearing on the fields of human performance (e.g. hypertrophy, strength or endurance adaptations [1,2]) and human health (countering muscle atrophy and deconditioning occurring in older age or with conditions such as cancer cachexia [3,4], respiratory disease or medically enforced immobilization (e.g. hospitalized bed-rest, cast-immobilization [5,6])). The molecular regulation of muscle hypertrophy has mostly focused on aspects of post-genomic signaling, with early work concluding that canonical insulin-like growth factor (IGF-1) signals control muscle hypertrophy though a phosphatidyl-inositol kinase/protein kinase B/mechanistic target of rapamycin (PI3K/AKT/mTORc1) pathway [10], abbreviated to mTOR. This protein complex can control cell growth through two mechanisms; firstly, mTORC1 regulates efficiency of translation

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call